Cardiff Oncology, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Cardiff Oncology, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
  • Cardiff Oncology, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $107K.
  • Cardiff Oncology, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $0.000, a 100% decline from 2022.
  • Cardiff Oncology, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $75K, a 99.8% decline from 2021.
  • Cardiff Oncology, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $35.5M, a 74.2% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 -$75K -100% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $75K -$35.4M -99.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $35.5M -$102M -74.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $137M +$125M +1037% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 $12.1M -$4.33M -26.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 $16.4M Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.